Spero Therapeutics Company
Spero Therapeutics is developing first in class therapeutics for treatment of Gram-negative infections.
Technology:
Biologics
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2013
Employees Number:
11-50
Funding Status:
IPO
Total Funding:
421400000
Estimated Revenue:
$1M to $10M
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership